Study on the Prevalence of Human Papillomavirus Types in Women >= 15 Years of Age in the Kingdom of Saudi Arabia
NCT01213459 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 420
Last updated 2012-11-22
Summary
This study aims to determine the prevalence of human papillomavirus (HPV) and to assess the HPV type distribution among women \>= 15 years of age, attending routine gynaecological examination in the Kingdom of Saudi Arabia.
Conditions
- Infections, Papillomavirus
- Cervical Cancer
Interventions
- PROCEDURE
-
Cervical samples
Human papillomavirus detection and typing in cervical samples.
- OTHER
-
Data collection
Questionnaire completion
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · GlaxoSmithKline
Eligibility
- Min Age
- 15 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-04-30
- Primary Completion
- 2011-12-31
- Completion
- 2011-12-31
Countries
- Saudi Arabia
Study Locations
More Related Trials
-
Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects
NCT01190176 ·Status: COMPLETED ·Phase: PHASE3
-
Gynaecological Follow-up of a Subset of 580299/008 (NCT00122681) Study Subjects
NCT00937950 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Natural History of Human Papillomavirus (HPV) Infections in Adult Women With Recurrent Conizations in Norway
NCT00924794 ·Status: TERMINATED
-
Type Distribution of Human Papillomavirus in Adult African Women Diagnosed With Invasive Cervical Cancer
NCT01207999 ·Status: COMPLETED
-
Human Papillomavirus (HPV) Type Distribution in Adult Women Diagnosed With Invasive Cervical Cancer in New Zealand
NCT01328028 ·Status: COMPLETED
-
Effectiveness of Cervical Screening in HPV Vaccinated Women
NCT02149030 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study for Prevention of Cervical Cancer in Spain
NCT07113379 ·Status: NOT_YET_RECRUITING
-
Protective Efficacy of HPV Vaccination After Treatment of HPV Related Diseases
NCT05085093 ·Status: UNKNOWN
-
Effect of HPV Vaccination on Women Aged 25 Years
NCT02296255 ·Status: COMPLETED ·Phase: PHASE4
-
Cross-sectional Study on Human Papillomavirus Type Distribution in Adult Women Diagnosed With Cervical Cancer
NCT01221987 ·Status: COMPLETED
-
Non-Invasive Plasma Treatment for Cervical Infections: Targeting High- and Low-Risk HPV Variants
NCT06291311 ·Status: RECRUITING
-
Human Papillomavirus (HPV) Vaccination in Barretos (Pio XII Foundation - Barretos Cancer Hospital)
NCT01159834 ·Status: COMPLETED
-
Cervical Cancer Screening of Postmenopausal Women in Low- and Middle-income Countries Using HPV Self-sampling and Triage by Genotyping and Cytology
NCT07244315 ·Status: COMPLETED
-
Use of Human Papillomavirus Persistence for Determination of Treatment Efficacy Among Women With Cervical Dysplasia
NCT00931190 ·Status: COMPLETED
-
HPV-based Screening Among Women 23-29 Years of Age
NCT05229679 ·Status: RECRUITING ·Phase: NA
-
HPV Prevalence in the Mouth and Oropharynx of the Tonsillectomy Population
NCT01330147 ·Status: COMPLETED
-
Randomized Implementation of Primary HPV Testing in the Organized Screening for Cervical Cancer in Stockholm
NCT01511328 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Clinical Evaluation of the APTIMA® HPV Assay and Comparison With the HR HC2® Test Using LBC ThinPrep® Specimens
NCT02634190 ·Status: COMPLETED
-
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S03)
NCT06611540 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Retrospective Cohort Study of the Effectiveness of the Prophylactic Vaccine Against the Human Papilloma Virus in the Prevention of Recurrence in Women Who Have Received an Excisional Therapy by HSIL / CIN.
NCT04171505 ·Status: UNKNOWN
-
HPV Vaccine Effectiveness Study in Rwandan Women Living With HIV
NCT05247853 ·Status: COMPLETED
-
Impact of HPV Vaccine On The Prevalence Of HPV In Norway
NCT02934724 ·Status: COMPLETED
-
Prevalence of HPV Infection Using Self-sampling
NCT03474211 ·Status: COMPLETED
-
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S01)
NCT06498661 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Immunogenicity and Safety Study of NBP615 in Healthy Female
NCT04453241 ·Status: COMPLETED ·Phase: PHASE1/PHASE2